KOSDAQ - Delayed Quote KRW

Cell Bio Human Tech Co.,Ltd (318160.KQ)

5,800.00
-350.00
(-5.69%)
At close: May 16 at 3:30:30 PM GMT+9
Loading Chart for 318160.KQ
  • Previous Close 6,150.00
  • Open 6,490.00
  • Bid 5,840.00 x --
  • Ask 5,850.00 x --
  • Day's Range 5,800.00 - 6,490.00
  • 52 Week Range 2,875.00 - 6,640.00
  • Volume 60,121
  • Avg. Volume 97,115
  • Market Cap (intraday) 49.186B
  • Beta (5Y Monthly) 0.37
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Cell Bio Human Tech Co.,Ltd develops and manufactures cellulose mask pack material by using cellulose reaction technology. It offers PT CELL that is made of bamboo cellulose material with skin adhesion and absorption; NF CELL, a material made from eucalyptus tree extract; S CELL, a cellulose sheet that tightly wraps the skin with a soft touch and high adhesion; S BR, a transparent and a sense of adhesion; and SEMI GEL, a cellulose fiber sheet with gel-like transparency and touch. The company was founded in 2015 and is headquartered in Ansan, South Korea.

cellbiohumantech.co.kr

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 318160.KQ

View More

Performance Overview: 318160.KQ

Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .

YTD Return

318160.KQ
84.13%
KOSPI Composite Index (^KS11)
9.48%

1-Year Return

318160.KQ
33.33%
KOSPI Composite Index (^KS11)
4.58%

3-Year Return

318160.KQ
38.17%
KOSPI Composite Index (^KS11)
1.17%

5-Year Return

318160.KQ
38.17%
KOSPI Composite Index (^KS11)
36.30%

Compare To: 318160.KQ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 318160.KQ

View More

Valuation Measures

Annual
As of 5/16/2025
  • Market Cap

    49.19B

  • Enterprise Value

    39.39B

  • Trailing P/E

    11.81

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.82

  • Price/Book (mrq)

    1.07

  • Enterprise Value/Revenue

    1.39

  • Enterprise Value/EBITDA

    5.25

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    15.41%

  • Return on Assets (ttm)

    4.76%

  • Return on Equity (ttm)

    9.63%

  • Revenue (ttm)

    28.42B

  • Net Income Avi to Common (ttm)

    4.38B

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    14.31B

  • Total Debt/Equity (mrq)

    8.76%

  • Levered Free Cash Flow (ttm)

    5.63B

Research Analysis: 318160.KQ

View More

Company Insights: 318160.KQ

Research Reports: 318160.KQ

View More

People Also Watch